Treatment of Peripheral Precocious Puberty
Authors:
- Melissa SchoelwerMSMelissa Schoelwer
- Erica A. EugsterEEErica A. Eugster
- 17 December 2015
- book chapter
- Published by S. Karger AG
- Vol. 29, 230-239
Abstract
There are many etiologies of peripheral precocious puberty (PPP) with diverse manifestations resulting from exposure to androgens, estrogens, or both. The clinical presentation depends on the underlying process and may be acute or gradual. The primary goals of therapy are to halt pubertal development and restore sex steroids to prepubertal values. Attenuation of linear growth velocity and rate of skeletal maturation in order to maximize height potential are additional considerations for many patients. McCune-Albright syndrome (MAS) and familial male-limited precocious puberty (FMPP) represent rare causes of PPP that arise from activating mutations in GNAS1 and the LH receptor gene, respectively. Several different therapeutic approaches have been investigated for both conditions with variable success. Experience to date suggests that the ideal therapy for precocious puberty secondary to MAS in girls remains elusive. In contrast, while the number of treated patients remains small, several successful therapeutic options for FMPP are available.Keywords
This publication has 26 references indexed in Scilit:
- Incidence and Characteristics of Pseudoprecocious Puberty Because of Severe Primary HypothyroidismThe Journal of Pediatrics, 2013
- Fulvestrant treatment of precocious puberty in girls with McCune-Albright syndromeInternational Journal of Pediatric Endocrinology, 2012
- McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasiaOrphanet Journal of Rare Diseases, 2012
- Aromatase inhibitors in pediatricsNature Reviews Endocrinology, 2011
- Bicalutamide and Third-Generation Aromatase Inhibitors in TestotoxicosisPediatrics, 2010
- Long‐term treatment of familial male‐limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazoleClinical Endocrinology, 2008
- Clinical Presentation of McCune-Albright Syndrome in MalesJournal of Pediatric Endocrinology and Metabolism, 2006
- Hazards of ketoconazole therapy in testotoxicosisActa Paediatrica, 1994
- Final Height Attainment and Gonadal Function in Girls with Precocious Puberty Treated with Cyproterone AcetateHormone Research, 1992
- Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: Familial testotoxicosisThe Journal of Pediatrics, 1985